Can a lupus drug help when given early?
NCT ID NCT03543839
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests the drug belimumab (Benlysta) in 30 people who were diagnosed with lupus within the last two years. Participants will receive either the drug or a placebo for one year, and then some may switch to placebo in the second year. The goal is to see if early treatment can control the disease and change how the immune system behaves.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- belimumab (Benlysta)
- What this could lead to
- If it works, this could point toward a treatment that controls lupus early on, potentially reducing long-term damage.
- What could go wrong
- This is a small pilot trial with only 30 people, so results may not apply to everyone. The drug may not work better than placebo, and side effects like infections are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Feinstein Institute
RECRUITINGManhasset, New York, 11030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new antibody help lupus patients ditch steroids?
- Ear zap may calm lupus pain by taming inflammation
- Engineered immune cells take aim at Hard-to-Treat lupus
- Are women with autoimmune diseases getting the gynecological care they need?
- New drug cevostamab enters early human testing for lupus
- Ancient chinese practice tested to ease lupus fatigue and stress